madopar 62.5 capsules
roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar 125 capsules
roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar 250 capsules
roche pharma (schweiz) ag - levodopum, benserazidum - capsules - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar 250 comprimés
roche pharma (schweiz) ag - levodopum, benserazidum - comprimés - levodopum 200.00 mg, benserazidum 50.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.01 mg, magnesii stearas, pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar 125 comprimés
roche pharma (schweiz) ag - levodopum, benserazidum - comprimés - levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.005 mg, magnesii stearas, pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar liq 62.5 comprimés pour suspension buvable
roche pharma (schweiz) ag - levodopum, benserazidum - comprimés pour suspension buvable - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, acidum citricum, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar liq 125 comprimés pour suspension buvable
roche pharma (schweiz) ag - levodopum, benserazidum - comprimés pour suspension buvable - levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, acidum citricum, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika
madopar dr comprimés
roche pharma (schweiz) ag - levodopum, benserazidum - comprimés - levodopum 200.000 mg, benserazidum 50.000 mg ut benserazidi hydrochloridum, hypromellosum, mannitolum, e 172 (rubrum), povidonum k 30, magnesii stearas, silica colloidalis hydrica, ricini oleum hydrogenatum, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 2.9 mg, pro compresso. - morbus parkinson, des jambes sans repos-syndrom - synthetika
cacit 500 mg compr. efferv.
theramex ireland ltd. - carbonate de calcique 1250 mg - eq. calcium 500 mg - comprimé effervescent - 500 mg - carbonate de calcique 1250 mg - calcium carbonate
cacit 1 000 mg compr. efferv.
theramex ireland ltd. - carbonate de calcique 2500 mg - eq. calcium 1000 mg - comprimé effervescent - 1000 mg - carbonate de calcique 2500 mg - calcium carbonate